Can we track brain health in older cancer patients?
NCT ID NCT07411105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether it's possible to track memory and thinking changes in adults aged 65 and older who are starting a new type of cancer treatment called immune checkpoint inhibitors. Thirty participants will take simple memory and concentration tests every six weeks for six months. The goal is to see if people will join and stick with the study, and to gather early information about how these treatments might affect brain function over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. James's Hospital, Dublin
Dublin, Dublin, D09HP89, Ireland
-
St. Vincent's University Hospital, Dublin
Dublin, Dublin, D09HP89, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- Can we rethink surgery care for seniors?
- A simple screening program could transform cancer aftercare